Investments
British Patient Capital announces £20m commitment to Cambridge Innovation Capital £100m Opportunity Fund
British Patient Capital, a commercial subsidiary of the British Business Bank, has made a £20 million cornerstone commitment to Cambridge Innovation Capital’s (CIC) £100 million Opportunity Fund, alongside Aviva Investors.CIC was launched in 2013 and invests in deep tech and life scienc...
New £100m Cambridge Innovation Capital fund launched
Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growing DeepTech and life science companies.The aim is to help our best businesses clinch growth capital in the UK rather than being for...
Epitopea announces license and research collaboration agreement with MSD to identify cryptigenTM tumor-specific antigens
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to identify CryptigenTM tumor-specif...
Cambridge GaN Devices secures $32M to drive growth in power semiconductor industry
Cambridge GaN Devices (CGD), a leading innovator in gallium nitride (GaN) power devices, has successfully closed a $32 million Series C funding round. The investment was led by a strategic investor with participation from British Patient Capital and supported by existing investors Parkw...
Salience Labs closed Series A round led by Applied Ventures and ICM HPQC Fund
Salience Labs Limited, a leader in photonic solutions targeting connectivity for AI datacenter infrastructure, today announced the successful close of $30 million in Series A financing led by ICM HPQC Fund and Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc., to...
R42-AlgoDynamix: Markets or Mania (special edition event!)
Join financial innovation leaders Dr. Jeremy Sosabowski (AlgoDynamix CEO), Prof. Ronjon Nag (R42 Founder), and Prof. Frank Sortino (Sortino ratio creator) as they decode whether we're witnessing rational markets or investment mania. Gain valuable insights on risk management strategies t...
BioBeat25: Getting ahead of the curve in biotech
Leaders in life sciences will discuss success in biotech through forward-thinking. Biotech and Partnering Hotspots will explore key areas, where partnerships tend to be struck and the drivers behind such deals. Nailing the Fundraise will discuss the practical side of closing a financing...
Cambridge's brightest stars at the Digital Commonwealth Awards 2025
London & Cambridge (UK) April 2025: Cambridge continues to cement its reputation as a hub of global business innovation and technological excellence, with four standout organisations nominated as finalists for the Digital Commonwealth Awards 2025. The nominees are AlgoDyna...
AlgoDynamix Podcast Series with special guest Robert Carver
AlgoDynamix Podcast Series with special guest Robert Carver London & Cambridge (UK) and Toronto (Canada). AlgoDynamix, the leader in behavioural-based price forecasting for financial markets, continues its podcast series with experts from the financial servi...
Focus on Finance – Ponder, Pitch and Partner
We navigate the various funding options, from non-dilutive to debt and equity finance, to help you decide what is best for your business. Then we’ll be hearing from a line-up of ventures seeking finance, with the chance to meet investors and have those all-important partnering meetings...